In situ assessment of Mindin as a biomarker of podocyte lesions in diabetic nephropathy. Martins ALMDS, Bernardes AB, Ferreira VA, Wanderley DC, et al. PLoS One 2023;18:e0284789.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Martins ALMDS, Bernardes AB, Ferreira VA, Wanderley DC, et al. In situ assessment of Mindin as a biomarker of podocyte lesions in diabetic nephropathy. PLoS One 2023;18:e0284789.
PMID: 37130106